Hope Rugo Professor of Medicine; Director, Breast Oncology and Clinical Trials Education; UCSF Comprehensive Cancer Center 5Live #ASCO20
6:09
"Key Insights on A phase Ib study of abemaciclib in combination with pembrolizumab for pts with HR+/HER2- locally advanced or MBC (NCT02779751): Interim results "
Breast Cancer
Hope Rugo Professor of Medicine; Director, Breast Oncology and Clinical Trials Education; UCSF Comprehensive Cancer Center 5Live #ASCO20
"Key Insights on A phase Ib study of abemaciclib in combination with pembrolizumab for pts with HR+/HER2- locally advanced or MBC (NCT02779751): Interim results "
Breast Cancer Similar Videos
Similar Videos
-
Sara Hurvitz, MD; University of California Los Angeles; 5Live #SABCS21
5:47
Key insights from the 2021 Annual Breast meeting in San Antonio
-
Building Health Equity and Multidirectional Trust in Cancer Care_Breast & Colorectal Cancer_Lisa Newman, MD, MPH, FACS, FASCO, FSSO_Laura Musselwhite, MD, MPH
50:13
-
Kevin Kalinsky, MD, MS; Emory University Winship Cancer Institute; #DDHO2022
15:55
